Literature DB >> 11790612

Targeted taxane therapy for cancer.

Jo Whelan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790612     DOI: 10.1016/s1359-6446(01)02149-3

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


× No keyword cloud information.
  4 in total

Review 1.  Tumor-targeting drug delivery of new-generation taxoids.

Authors:  Iwao Ojima; Edison S Zuniga; William T Berger; Joshua D Seitz
Journal:  Future Med Chem       Date:  2012-01       Impact factor: 3.808

Review 2.  Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species.

Authors:  Sharon C-A Chen; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Virulence       Date:  2011-07-01       Impact factor: 5.882

3.  Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study.

Authors:  Rishil J Kathawala; Kamlesh Sodani; Kang Chen; Atish Patel; Alaa H Abuznait; Nagaraju Anreddy; Yue-Li Sun; Amal Kaddoumi; Charles R Ashby; Zhe-Sheng Chen
Journal:  Mol Cancer Ther       Date:  2014-01-15       Impact factor: 6.261

4.  Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer.

Authors:  Steve Knutson; Erum Raja; Ryan Bomgarden; Marie Nlend; Aoshuang Chen; Ramaswamy Kalyanasundaram; Surbhi Desai
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.